IPRIPR2026-00150Trial Instituted
Sarepta Therapeutics, Inc. et al.v.Genzyme Corporation et al.
IPR challenge of US 12031894.
Type
IPR
Filed
Nov 25, 2025
Instituted
May 6, 2026
Decided
May 6, 2026
Patent
Application
18513970
Inventor
Catherine R. O'RIORDAN et al
Granted
Jul 9, 2024
01
Timeline
2 milestones
2025-11-25Petition filed
2026-05-06Institution
02
Parties & counsel
Petitioner
Sarepta Therapeutics, Inc. et al.
Counsel
Weingarten, Martinet al
Patent Owner
Genzyme Corporation et al.
Counsel
Antons, Amandaet al
03
Docket
Documents are mirrored from the PTAB e-file system. Filer is as stated on the face of the filing.
SOURCE · USPTO PTAB E2EView on Unified Patents →